Probiotec

Probiotec, founded in 1997 and headquartered in Laverton North, Victoria, Australia, is a prominent player in the pharmaceutical and healthcare sectors. The company specializes in the manufacturing, marketing, and distribution of prescription pharmaceuticals, over-the-counter (OTC) medicines, and complementary health products. Through its subsidiaries, Probiotec Pharma and Probiotec Multipack, it offers specialized contract manufacturing and secondary packaging services. Probiotec is committed to driving innovation and maintaining high standards of quality across its diverse product portfolio, serving both domestic and international markets.

The company's operational capabilities extend to catering to a broad spectrum of industries, including food, personal care, and pharmaceuticals, by providing comprehensive contract manufacturing and packaging solutions. Probiotec targets blue-chip manufacturers and Fast-Moving Consumer Goods (FMCG) clients, leveraging advanced facilities and experienced personnel to deliver tailored, high-quality outcomes. Operating with 1,000-5,000 employees across 3 locations, Probiotec ensures efficient production and distribution. Potential partners and stakeholders can learn more about the dedicated professionals behind these operations by visiting Meet Probiotec's team.

Probiotec's product range encompasses prescription drugs, OTC pharmaceuticals, and a variety of complementary medicines and specialty ingredients. The company's strategic focus on quality and innovation positions it effectively within the competitive Australian healthcare landscape. Its market presence is supported by a robust understanding of regulatory requirements and consumer needs in the pharmaceutical and health sectors. Competitors include Mayne Pharma, Vitex Pharmaceuticals, and global entities like Perrigo and Teva, highlighting Probiotec's established position.